A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery

Yuchao Lu,* 1,2 Chenxi Hou,* 1 Jingli Ren,1 Kui Yang,1 Yincheng Chang,1 Yuxin Pei,1 Hai Dong,3 Zhichao Pei11Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry and Pharmacy, Northwest A&F University, Yangling, Shaanxi 712100, People&a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lu Y, Hou C, Ren J, Yang K, Chang Y, Pei Y, Dong H, Pei Z
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/7c2a6c3d1b6f4ad093196726893358e3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7c2a6c3d1b6f4ad093196726893358e3
record_format dspace
spelling oai:doaj.org-article:7c2a6c3d1b6f4ad093196726893358e32021-12-02T02:33:58ZA multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery1178-2013https://doaj.org/article/7c2a6c3d1b6f4ad093196726893358e32019-05-01T00:00:00Zhttps://www.dovepress.com/a-multifunctional-supramolecular-vesicle-based-on-complex-of-cystamine-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yuchao Lu,* 1,2 Chenxi Hou,* 1 Jingli Ren,1 Kui Yang,1 Yincheng Chang,1 Yuxin Pei,1 Hai Dong,3 Zhichao Pei11Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry and Pharmacy, Northwest A&F University, Yangling, Shaanxi 712100, People’s Republic of China; 2Analysis Center of College of Science & Technology, Hebei Agricultural University, Huanghua, Hebei 061100, People’s Republic of China; 3School of Chemistry & Chemical Engineering, Huazhong University of Science & Technology, Wuhan, Hubei 430074, People’s Republic of China *These authors contributed equally to this work Background: Supramolecular vesicles are a novel class of nanocarriers that have great potential in biomedicine.Methods: A multifunctional supramolecular vesicle (CAAP5G) based on the complex of CAAP5 and galactose derivative (G) assembled via host-guest interaction was constructed.Results: Using Human embryonic kidney T (293T) cells as experimental models, the cytotoxic effects of CAAP5G was investigated to 0–50 μmol/L for 24 h. Notably, the CAAP5G vesicles revealed low-toxicity to 293T cells, it was critical to designing drug nano-carriers. Simultaneously, we have evaluated doxorubicin hydrochloride (DOX)-loaded CAAP5G vesicles anticancer efficiency, where DOX-loaded CAAP5G vesicles and free DOX incubated with Human hepatocellular carcinoma cancer cell (HpeG2 cells) and 293T cells for 24 h, 48 h, 72 h. It turned out that CAAP5G vesicles encapsulated anticancer drug (DOX) could decrease DOX side-effect on 293T cells and increase DOX anticancer efficiency. More importantly, the cysteamine as an adjuvant chemotherapy drug was released from CAAP5G vesicles in HepG2 cells where a higher GSH concentration exists. The adjuvant chemotherapy efficiency was evaluated, where free DOX and DOX-loaded CAAP5G vesicles incubated with DOX-resistance HepG2 cells (HepG2-ADR cells) for 24, 48, 72 h, respectively.Conclusion: The results revealed that the DOX encapsulated by CAAP5G vesicles could enhance the cytotoxicity of DOX and provide insights for designing advanced nano-carriers toward adjuvant chemotherapies.es.Keywords: supramolecular vesicles, cysteamine, responsive, adjuvant chemotherapies, targeted drug deliveryLu YHou CRen JYang KChang YPei YDong HPei ZDove Medical Pressarticlesupramolecular vesiclescysteamineresponsiveadjuvant chemotherapiestargeted drug deliveryMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 3525-3532 (2019)
institution DOAJ
collection DOAJ
language EN
topic supramolecular vesicles
cysteamine
responsive
adjuvant chemotherapies
targeted drug delivery
Medicine (General)
R5-920
spellingShingle supramolecular vesicles
cysteamine
responsive
adjuvant chemotherapies
targeted drug delivery
Medicine (General)
R5-920
Lu Y
Hou C
Ren J
Yang K
Chang Y
Pei Y
Dong H
Pei Z
A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
description Yuchao Lu,* 1,2 Chenxi Hou,* 1 Jingli Ren,1 Kui Yang,1 Yincheng Chang,1 Yuxin Pei,1 Hai Dong,3 Zhichao Pei11Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry and Pharmacy, Northwest A&F University, Yangling, Shaanxi 712100, People’s Republic of China; 2Analysis Center of College of Science & Technology, Hebei Agricultural University, Huanghua, Hebei 061100, People’s Republic of China; 3School of Chemistry & Chemical Engineering, Huazhong University of Science & Technology, Wuhan, Hubei 430074, People’s Republic of China *These authors contributed equally to this work Background: Supramolecular vesicles are a novel class of nanocarriers that have great potential in biomedicine.Methods: A multifunctional supramolecular vesicle (CAAP5G) based on the complex of CAAP5 and galactose derivative (G) assembled via host-guest interaction was constructed.Results: Using Human embryonic kidney T (293T) cells as experimental models, the cytotoxic effects of CAAP5G was investigated to 0–50 μmol/L for 24 h. Notably, the CAAP5G vesicles revealed low-toxicity to 293T cells, it was critical to designing drug nano-carriers. Simultaneously, we have evaluated doxorubicin hydrochloride (DOX)-loaded CAAP5G vesicles anticancer efficiency, where DOX-loaded CAAP5G vesicles and free DOX incubated with Human hepatocellular carcinoma cancer cell (HpeG2 cells) and 293T cells for 24 h, 48 h, 72 h. It turned out that CAAP5G vesicles encapsulated anticancer drug (DOX) could decrease DOX side-effect on 293T cells and increase DOX anticancer efficiency. More importantly, the cysteamine as an adjuvant chemotherapy drug was released from CAAP5G vesicles in HepG2 cells where a higher GSH concentration exists. The adjuvant chemotherapy efficiency was evaluated, where free DOX and DOX-loaded CAAP5G vesicles incubated with DOX-resistance HepG2 cells (HepG2-ADR cells) for 24, 48, 72 h, respectively.Conclusion: The results revealed that the DOX encapsulated by CAAP5G vesicles could enhance the cytotoxicity of DOX and provide insights for designing advanced nano-carriers toward adjuvant chemotherapies.es.Keywords: supramolecular vesicles, cysteamine, responsive, adjuvant chemotherapies, targeted drug delivery
format article
author Lu Y
Hou C
Ren J
Yang K
Chang Y
Pei Y
Dong H
Pei Z
author_facet Lu Y
Hou C
Ren J
Yang K
Chang Y
Pei Y
Dong H
Pei Z
author_sort Lu Y
title A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
title_short A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
title_full A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
title_fullStr A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
title_full_unstemmed A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
title_sort multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/7c2a6c3d1b6f4ad093196726893358e3
work_keys_str_mv AT luy amultifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT houc amultifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT renj amultifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT yangk amultifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT changy amultifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT peiy amultifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT dongh amultifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT peiz amultifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT luy multifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT houc multifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT renj multifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT yangk multifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT changy multifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT peiy multifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT dongh multifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
AT peiz multifunctionalsupramolecularvesiclebasedoncomplexofcystaminedihydrochloridecappedpillar5areneandgalactosederivativefortargeteddrugdelivery
_version_ 1718402417544921088